Does providing cost-effectiveness information change coverage priorities for citizens acting as social decision makers?

Health Policy

Volumn 83, Issue 1, 2007, Pages 65-72

  Gold, Marthe Rachel ^a   Franks, Peter ^b   Siegelberg, Taryn ^a   Sofaer, Shoshanna ^c  

^a CITY UNIVERSITY OF NEW YORK MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Cost effectiveness analysis; Deliberative focus groups; Medicare; Public opinion

Indexed keywords

ARTICLE; CITIZENSHIP; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; HEALTH CARE; HEALTH CARE COST; HEALTH INSURANCE; HEALTH STATUS; HEALTH SURVEY; HUMAN; MEDICARE; QUANTITATIVE ANALYSIS; SOCIAL ASPECT;

ADOLESCENT; ADULT; AGED; CONSUMER SATISFACTION; COST-BENEFIT ANALYSIS; DECISION MAKING, ORGANIZATIONAL; FEMALE; FOCUS GROUPS; HUMANS; INSURANCE COVERAGE; MALE; MEDICARE; MIDDLE AGED; NEW YORK; UNITED STATES;

EID: 34447297789     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healthpol.2006.11.012     Document Type: Article

References (49)

1. Cutler DM, The Potential For Cost Savings In Medicare's Future. Health Affairs (Millwood); 2005. Web-exclusive Suppl. 2, vol. 24, pR77-R80, 4p.
2. The Henry J. Kaiser Foundation, Fact Sheet: Medicare at a Glance. Washington, DC; 2005. www.kff.org/medicare/1066.cfm
3. Regenstreif D.I. Medicare's cost crisis: solutions are within our grasp. Health Affairs (Millwood) 24 Suppl. 2 (2005) W5R90-3
4. Gillick M.R. Medicare coverage for technological innovations-time for new criteria?. New England Journal of Medicine 350 21 (2004) 2199-2203
5. Neumann P.J., Rosen A.B., and Weinstein M.C. Medicare and cost-effectiveness analysis. New England Journal of Medicine 353 14 (2005) 1516-1522
6. Gold M. Cost-effectiveness in health and medicine (1996), Oxford University Press
7. Russell L.B., Gold M.R., Siegel J.E., Daniels N., and Weinstein M.C. The role of cost-effectiveness analysis in health and medicine. Panel on cost-effectiveness in health and medicine. The Journal of the American Medical Association 276 14 (1996) 1172-1177
8. Weinstein M.C., Siegel J.E., Gold M.R., Kamlet M.S., and Russell L.B. Recommendations of the panel on cost-effectiveness in health and medicine. The Journal of the American Medical Association 276 15 (1996) 1253-1258
9. Drummond M.F., and Jefferson T.O. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. British Medical Journal 313 7052 (1996) 275-283
10. Kassirer J.P., and Angell M. The journal's policy on cost-effectiveness analyses. New England Journal of Medicine 331 10 (1994) 669-670
11. Garber A.M. Cost-effectiveness and evidence evaluation as criteria for coverage policy. Health Affairs (Millwood) Suppl. (2004) W4-284-96 [Web exclusives]
12. Neumann P. Using cost-effectiveness analysis to improve health care (2005), Oxford University Press, New York, NY p. 224
13. Siegel J.E. Cost-effectiveness analysis in US healthcare decision-making: where is it going?. Medical Care 43 Suppl. 7 (2005) 1-4
14. Garber A.M. Evidence-based coverage policy. Health Affairs (Millwood) 20 5 (2001) 62-82
15. Luce B.R., Lyles C.A., and Rentz A.M. The view from managed care pharmacy. Health Affairs (Millwood) 15 4 (1996) 168-176
16. Sloan F.A., and Grabowski H.G. The impact of cost-effectiveness on public and private policies in health care: an international perspective. Introduction and overview. Social Science and Medicine 45 4 (1997) 505-510
17. Kowalczyk L. Drug costs still ensnare health plans rise of 14-19% seen despite control effects (2002), The Boston Globe, Boston, MA
18. Jacobson P.D., and Kanna M.L. Cost-effectiveness analysis in the courts: recent trends and future prospects. Journal of Health, Politics, Policy and Law 26 2 (2001) 291-326
19. Bowie C., Richardson A., and Sykes W. Consulting the public about health service priorities. British Medical Journal 311 7013 (1995) 1155-1158
20. Lenaghan J. Involving the public in rationing decisions. The experience of citizens juries. Health Policy 49 1-2 (1999) 45-61
21. Lomas J. Reluctant rationers: public input to health care priorities. Journal of Health, Services, Research and Policy 2 2 (1997) 103-111
22. Abelson J., Forest P.G., Eyles J., Smith P., Martin E., and Gauvin F.P. Deliberations about deliberative methods: issues in the design and evaluation of public participation processes. Social Science and Medicine 57 2 (2003) 239-251
23. Dolan P., Cookson R., and Ferguson B. Effect of discussion and deliberation on the public's views of priority setting in health care: focus group study. British Medical Journal 318 7188 (1999) 916-919
24. Bowling A., Jacobson B., and Southgate L. Explorations in consultation of the public and health professionals on priority setting in an inner London health district. Social Science and Medicine 37 7 (1993) 851-857
25. Roberts T., Bryan S., Heginbotham C., and McCallum A. Public involvement in health care priority setting: an economic perspective. Health Expectations 2 4 (1999) 235-244
26. Bryan S., Roberts T., Heginbotham C., and McCallum A. QALY-maximisation and public preferences: results from a general population survey. Health Economics 11 8 (2002) 679-693
27. Dolan P., and Shaw R. A note on the relative importance that people attach to different factors when setting priorities in health care. Health Expectations 6 1 (2003) 53-59
28. McIver S. Information for public choice. British Medical Bulletin 51 (1995) 900-913
29. Delap C. Making better decisions: report of an IPPR symposium, Citizen's Juries and other methods of public involvement. London, England: Institute For Public Policy Research; 1998, p. 27.
30. Gold M.R. Tea, biscuits, and health care prioritising. Health Affairs (Millwood) 24 1 (2005) 234-239
31. Hadorn D.C., and Holmes A.C. The New Zealand priority criteria project. Part 1. Overview. British Medical Journal 314 7074 (1997) 131-134
32. Bloomfield A., and Logan R. Quality improvement perspective and healthcare funding decisions. British Medical Journal 327 7412 (2003) 439-443
33. Nord E., Richardson J., Street A., Kuhse H., and Singer P. Who cares about cost? Does economic analysis impose or reflect social values?. Health Policy 34 2 (1995) 79-94
34. Bodenheimer T. The Oregon health plan-lessons for the nation. First of two parts. New England Journal of Medicine 337 9 (1997) 651-655
35. Sacramento Health Decisions, Cost-Effectiveness as a Criterion for Medical and Coverage Decisions. Understanding and Responding to Community Perspectives. Sacramento, CA; 2001.
36. Ginsburg M.E. Cost-effectiveness: will the public buy it or balk?. Health Affairs (Millwood) Suppl. (2004) W4-297-9 [Web exclusives]
37. Beach M.C., Asch D.A., Jepson C., Hershey J.C., Mohr T., McMorrow S., et al. Public response to cost-quality tradeoffs in clinical decisions. Medical Decision Making 23 5 (2003) 369-378
38. Gold MR, Sofaer S. Deliberative focus groups: citizen input to health policy. Prepared for the Agency for Health care Research and Quality, New York, NY; 2005.
39. Kutner J.S., Westfall J.M., Morrison E.H., Beach M.C., Jacobs E.A., and Rosenblatt R.A. Facilitating collaboration among academic generalist disciplines: a call to action. Annals of Family Medicine 4 2 (2006) 172-176
40. Hadorn D.C. Setting health care priorities in Oregon. Cost-effectiveness meets the rule of rescue. The Journal of the American Medical Association 265 17 (1991) 2218-2225
41. Nord E., Pinto J.L., Richardson J., Menzel P., and Ubel P. Incorporating societal concerns for fairness in numerical valuations of health programmes. Health Economics 8 1 (1999) 25-39
42. Williams A. Intergenerational equity: an exploration of the 'fair innings' argument. Health Economics 6 2 (1997) 117-132
43. Menzel P., Gold M.R., Nord E., Pinto-Prades J.L., Richardson J., and Ubel P. Toward a broader view of values in cost-effectiveness analysis of health. The Hastings Center Report 29 3 (1999) 7-15
44. Prosser L.A., Stinnett A.A., Goldman P.A., Williams L.W., Hunink M.G., Goldman L., et al. Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics. Annals of Internal Medicine 132 10 (2000) 769-779
45. Ganz D.A., Kuntz K.M., Jacobson G.A., and Avorn J. Cost-effectiveness of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor therapy in older patients with myocardial infarction. Annals of Internal Medicine 132 10 (2000) 780-787
46. Harvard Center For Risk Analysis. The CEA registry. Harvard School of Public Health; 2005.
47. Post AW. Healthcare Poll; 2003 [cited October 2003, available from: www.abcnews.go.com/sections/living/US/healthcare031020_poll.html].
48. Lee T.H., and Zapert K. Do high-deductible health plans threaten quality of care?. New England Journal of Medicine 353 12 (2005) 1202-1204
49. Rice T., and Matsuoka K.Y. The impact of cost-sharing on appropriate utilization and health status: a review of the literature on seniors. Medical Care Research Reviews 61 4 (2004) 415-452